Table 1.
Variable | No. of patients | Percentage | |
---|---|---|---|
Gender | Male | 18 | 54.5% |
Female | 15 | 45.5% | |
Age | Mean, median, range (years) | 61, 63, 40–75 | |
Smoking history | Smoker | 15 | 45.5% |
Non‐smoker | 18 | 54.5% | |
TMs | Positive | 10 | 30.3% |
Negative | 23 | 69.7% | |
LND classification | Solid nodule | 30 | 90.9% |
Part solid nodule | 3 | 9.1% | |
Preoperative biopsy | Yes | 18 | 54.5% |
No | 15 | 45.5% | |
Sequence of vessel interruption | PV‐PA | 19 | 57.6% |
PA‐PV | 14 | 42.4% | |
Histology | Adenocarcinoma | 25 | 75.8% |
Sq + others | 8 | 24.2% | |
pT stage | Mean, median, range (cm) | 2.7, 2.5, 1.2–4.5 | |
p stage | I | 21 | 63.6% |
II | 6 | 18.2% | |
III | 6 | 18.2% | |
pN stage | N0 | 23 | 69.7% |
N1–2 | 10 | 30.3% | |
Vessel/lymphatic invasion | Positive | 10 | 30.3% |
Negative | 23 | 69.7% | |
Pleural invasion | Positive | 5 | 15.2% |
Negative | 28 | 84.8% |
LND, lung nodule density; PA, pulmonary artery; pN stage, pathological N stage; pT stage, pathological T stage; PV, pulmonary vein; Sq, squamous cell carcinoma; TMs, tumor markers.